Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinical Outcomes and Ovarian Response of a Substantial Cohort
Darwish, F., Elmantwe, A., Elbanhawy, H., Abbas, A., El noury, M., Ahmed, A. (2024). Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinical Outcomes and Ovarian Response of a Substantial Cohort. EKB Journal Management System, 41(1), 1-6. doi: 10.21608/bmfj.2023.253331.1970
Fatma Faisal Ibrahim Darwish; Ashraf nassif Elmantwe; Hossam Elbanhawy; Ahmed Kamal Eldin Abbas; Mohamed Anwar El noury; ahmed mousad baioumy Ahmed. "Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinical Outcomes and Ovarian Response of a Substantial Cohort". EKB Journal Management System, 41, 1, 2024, 1-6. doi: 10.21608/bmfj.2023.253331.1970
Darwish, F., Elmantwe, A., Elbanhawy, H., Abbas, A., El noury, M., Ahmed, A. (2024). 'Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinical Outcomes and Ovarian Response of a Substantial Cohort', EKB Journal Management System, 41(1), pp. 1-6. doi: 10.21608/bmfj.2023.253331.1970
Darwish, F., Elmantwe, A., Elbanhawy, H., Abbas, A., El noury, M., Ahmed, A. Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinical Outcomes and Ovarian Response of a Substantial Cohort. EKB Journal Management System, 2024; 41(1): 1-6. doi: 10.21608/bmfj.2023.253331.1970

Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinical Outcomes and Ovarian Response of a Substantial Cohort

Benha Medical Journal
Article 1, Volume 41, Issue 1, March and April 2024, Page 1-6  XML PDF (958.24 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2023.253331.1970
View on SCiNiTO View on SCiNiTO
Authors
Fatma Faisal Ibrahim Darwish1; Ashraf nassif Elmantwe email orcid 2; Hossam Elbanhawy3; Ahmed Kamal Eldin Abbas4; Mohamed Anwar El noury5; ahmed mousad baioumy Ahmed6
1obstetrics and gynecology, Al-Qasr Al-Aini, Cairo University Egypt
2Benha faculty of medicine
3Teaching Hospitals Organization
4obstetrics and gynecology, Benha University Hospital, Benha University
5Assistant Professor of Obstetrics and Gynecology, Benha Faculty Of Medicine, Benha University, Egypt
6obstetrics & gynecology department, Benha University
Abstract
Background: Ovarian Stimulation Response (OSR) in polycystic ovarian syndrome (PCOS) ladies is a controversial issue
Aim: to evaluate outcomes of Fixed Progestin-Primed Ovarian Stimulation (FPPOS) and Flexible GnRH Antagonist Protocol (FGnRHan) on OSR and pregnancy outcomes in PCOS ladies undergoing intracytoplasmic sperm injection-frozen embryo transfer (ICSI-FET).
Patients and Methods: A retrospective assessment of PCOS ladies undergoing ICSI-FET cycles at Riyadh Fertility Center, Agouza, Giza Governorate (RFC), and Benha University Hospital (BUH), over the last 5 years. The outcomes were the frequencies of clinical pregnancy, continued pregnancy, live births, fertilization, early LH surge, and other OSR results.
Results: of 950 ladies included, 420 had FPPOS (study group) and 390 (control group) had the GnRHan protocol. Both groups' baseline metrics showed similarities. Mature and fertilized oocytes showed no discernible difference between the two groups (P > 0.5). Premature luteinization was rare in both groups, and there was no statistically significant difference (P > 0.5). Additionally, there was no discernible difference in the clinical pregnancy rate per frozen embryo transfer cycle (FETC) between the FGnRHan and FPPOS groups (P > 0.5). Also, continuing pregnancy rates, miscarriage rates, biochemical pregnancy rates, and implantation rates, showed statistical similarities across the groups (P > 0.05). However, there was a considerable decrease in cost calculated in local currency (5.8±3.1 vs. 8.8±4.1, p =0.001) between the FPPOS and FGnRHan groups.
Conclusion: in PCOS ladies who had ICSI-FET, the FPPOS protocol proves to be a powerful, practical, user-friendly, economical, and clinically equivalent alternative to the standard FGnRHan protocol.
Keywords
GnRH antagonist; PCOS; Progestins; PPOS; ICSI-FET
Statistics
Article View: 151
PDF Download: 143